European VC Funds

Forbion, a venture capital firm based in the Netherlands, specializes in investing in life sciences companies. Founded in 2006, Forbion focuses on drug development, medical devices, and diagnostics, addressing high medical needs. The firm has raised significant funds, including €190 million for its FCF I Co-Invest Fund and FCF II, targeting private companies primarily in Europe, with additional investments in North America and Israel. Forbion's notable portfolio companies include Replimune, a leader in oncolytic immunotherapies, and Gyroscope Therapeutics, which was acquired by Novartis. The firm has a strong track record with successful exits, such as the sale of Fovea Pharmaceuticals to Sanofi-Aventis and the acquisition of PanGenetics by Abbott. The firm is led by Managing Partner Bart Bergstein and has expanded its European presence with offices in Naarden and Munich. Forbion's investment strategy focuses on creating value through active involvement and leading investment syndicates in the life sciences sector.

Force Over Mass Capital, also known as FOMCAP, is a venture capital firm based in London, UK, founded in 2013. The firm focuses on early-stage investments, particularly in B2B technology sectors such as fintech, AI, SaaS, and deep tech. With a strong emphasis on leveraging technology and data analytics, FOMCAP supports innovative startups across the UK and Europe. Notable investments from FOMCAP include companies like Weavr, a financial software platform; Banxware, which provides embedded financial services for small and medium-sized businesses; and Admix, a platform for monetizing virtual experiences. The firm also has investments in Dopay, a payroll solution for unbanked workers, and Adhara, which offers real-time, multi-currency liquidity management and payment solutions. FOMCAP operates several funds, including the Seed Fund, which targets early-stage B2B tech startups, and the Growth Fund, focused on growth-stage opportunities from Series A to late-stage. The firm also manages dynamically structured index funds, catering to institutional investors like pension funds. Under the leadership of Martijn De Wever, FOMCAP integrates advanced data analytics and behavioral science assessments into its investment processes, enhancing the efficiency and success rate of its portfolio companies.

Foresight Group, established in 1984 and headquartered in London, is a leading private equity and infrastructure investment firm with a strong emphasis on sustainability and renewable energy. The firm manages over £7.2 billion in assets across various sectors, including clean energy, infrastructure, and private equity. Notable investments include Copperleaf, a business productivity software company, and several significant renewable energy projects like the Energy Works Hull and Shotwick Solar Park. Foresight Group’s strategy focuses on generating high returns through sustainable investments. They lead investment rounds and often provide substantial support and guidance to their portfolio companies. Their investments are spread across the UK, Europe, and Australia, with a notable presence in North America as well. Key team members include Tom Laidlaw (CEO), Gary Fraser (CFO), and co-founders Bernard Fairman and Peter English. The firm is highly regarded for its expertise in financial services and clean energy, having developed and managed several high-impact projects and funds, such as the Foresight Solar Fund Limited.

Forestay Capital is a Geneva-based venture capital firm focused on early growth-stage investments, primarily in enterprise AI and Software as a Service (SaaS) companies. Founded in 2018 as part of B-FLEXION (previously Waypoint Capital), the investment arm of the Bertarelli family, Forestay targets tech startups that are at pivotal inflection points, helping them scale from early revenue stages to market leadership. The firm typically invests between $10 million to $15 million and often leads funding rounds, emphasizing a hands-on approach to fostering growth. Forestay Capital has offices in Geneva, London, Jersey, and Dublin, reflecting its broad geographical focus on Europe and Israel, and occasionally the U.S. Notable investments include companies like Wasabi, a cloud storage provider that reached unicorn status, and Scandit, a leader in smart data capture. Recent successes also include funding rounds for startups such as Manta, Neural Concept, and Zenjob, highlighting their focus on sectors like data infrastructure, cybersecurity, and digital workforce solutions. The firm's strategy revolves around a concentrated portfolio, which allows it to provide deep operational support, leveraging its expertise to scale companies globally. With the recent close of its second fund, Forestay II, at $220 million, the firm continues to build on its commitment to backing category-defining companies that challenge conventional business models in tech​.

Foreword VC is a Berlin-based early-stage micro fund founded in 2021 by Declan Kelly, a solo GP with deep roots in the European startup community. Kelly previously led European coverage for Techstars Ventures and was a founding team member of Web Summit's venture fund Amaranthine; he also serves as advisor at Web Summit and entrepreneur-in-residence at Seedcamp. Foreword operates with the backing of more than 200 founders and operators who have built world-class technology companies, giving portfolio companies access to an unusually experienced mentor and advisor network for a fund of its size. The fund partners with approximately 10 companies annually, investing up to $250,000 at pre-seed and seed stages, with the ability to invest at Series A in existing relationships. Across 24 investments, Foreword has backed companies in B2B software, fintech, crypto, enterprise software, AI, marketplaces, and consumer sectors across the US and Europe. The portfolio includes three unicorns — Sorare, the digital sports platform; Jeeves, the global corporate card and expense platform; and Localyze, the global mobility platform — alongside two acquisitions. That unicorn density from a $250,000 check size represents an exceptional hit rate for a micro fund. Foreword's approach is relationship-driven and high-conviction rather than volume-driven. Kelly's background operating inside accelerators and venture networks gives him a structural edge in deal sourcing and in helping early-stage founders navigate the path to their first institutional round. Recent investments include Peec AI, Outverse, and Fyxer, which raised a Series B in September 2025.

FORM Life Ventures is a San Francisco-based healthcare venture capital firm founded in 2022, co-founded by Markus Okumus (Founding Partner) and Professor Tony Wyss-Coray (Scientific Founder), a renowned Stanford University neuroscientist known for his research on aging and blood-based biomarkers. The firm funds and incubates companies leveraging science and technology to drive the shift from traditional sickcare toward proactive, preventive healthcare. FORM Life writes first checks of $500,000 to $2 million, investing at seed and Series A stages across the US, Israel, UK, and Germany. The portfolio of six companies spans healthtech, biotech, and drug discovery. Known investments include RxDiet, an AI-driven food-as-medicine platform targeting chronic illnesses such as diabetes and hypertension, which raised a $3 million seed round in July 2024 led by Giant Ventures with FORM Life participating. The portfolio also includes Indomo, a drug discovery therapeutics company that raised $42.2 million in total from investors including Foresite Capital and Atomic14 Ventures. Other portfolio companies include Vero Bioscience, People Science, Teal Rise, and additional health platform companies. FORM Life's investment themes span e-health, medical devices, diagnostics, longevity, agetech, proteomics, digital health, mental health, connected health, and biomarker-based approaches to medicine. Professor Wyss-Coray's scientific credentials and Stanford network provide the firm with privileged access to some of the most advanced biomedical research emerging from the university, while Okumus's operational focus on company building bridges the gap between academic discovery and commercial healthcare applications.

Formula VC is a venture capital firm with a strong focus on early-stage investments in cutting-edge technology sectors like SaaS, IoT, and AI. The firm strategically supports startups primarily from Armenia and neighboring regions, aiming to transform local innovations into globally competitive companies. Formula VC’s investment strategy is built on a transatlantic approach, leveraging deep connections and expertise in both local and international markets. The firm’s portfolio reflects a commitment to identifying and nurturing high-potential startups at their critical early stages. Formula VC not only provides capital but also brings in strategic guidance, helping founders navigate the complexities of scaling a tech business globally. They often lead or co-lead investment rounds, ensuring that the startups receive the necessary resources to accelerate their growth and achieve market leadership. Formula VC’s team comprises seasoned investors and industry experts who have a track record of successfully guiding startups from seed to exit. Their experience spans multiple sectors and geographies, allowing them to offer valuable insights and mentorship to their portfolio companies. The firm is particularly interested in startups that demonstrate strong technological innovation and have the potential to disrupt traditional industries. For entrepreneurs looking to partner with Formula VC, the firm seeks out visionary founders with scalable ideas that can be adapted for international markets. They prioritize investments in companies that align with their mission of fostering technological advancement in underrepresented regions, helping to bridge the gap between local innovation and global success.

Fort Ross Ventures, formerly known as MoneyTime Ventures, is a global growth-stage venture capital firm founded in 2013 by Victor Orlovski, former CTO of Sberbank, one of Russia's largest financial institutions. The firm manages approximately $345 million in assets under management across multiple funds: Fund I of approximately $110 million, the $235 million oversubscribed Fund II that closed in March 2020, and a $200 million late-stage vehicle announced in 2021. Fort Ross operates from offices in Dubai (current headquarters), Istanbul, Milan, and Herzliya, Israel, with its general partners including Yacov Nachmanovich and Sharin Fisher leading activity in Israel. The firm invests in software, cybersecurity, fintech, big data, AI and machine learning, and proptech, with a sweet spot of $1.5 million per investment at Series A through growth stages and the ability to lead rounds. Its portfolio has produced two public listings — Tufin on NYSE and eToro on NASDAQ in May 2025 at a $2.31 billion market cap — and multiple notable acquisitions including Dynamic Yield, bought by McDonald's for $327 million, and CoverWallet, acquired by Aon. Uber also appears as a portfolio company from an earlier position. Fort Ross's structural advantage is its established relationships with financial institutions across Central and Eastern Europe and the Middle East through anchor LP partnerships. This network allows Fort Ross to create long-term commercial contracts and joint ventures between portfolio companies and LP networks, accelerating enterprise customer acquisition in markets where direct VC relationships are otherwise difficult for US or Israeli startups to build independently.

Forward Partners is a venture capital firm based in London that specializes in early-stage investments, particularly focusing on marketplace, applied AI, and Web3 opportunities. Founded in 2013 by Nicholas Brisbourne, the firm has a strong commitment to supporting founders from the initial stages through to seed investments, providing not just capital but also operational support and expertise. The firm's notable investments include companies such as Cazoo, Juno, Patch, and Pocdoc, reflecting a diverse portfolio across various technology sectors. Forward Partners has made 119 investments to date, with significant exits like Baselime and Lexoo. Their approach is unique in that they offer "thinking capital," which helps startups not only financially but also in developing scalable products, assembling high-performing teams, and creating robust sales pipelines. Forward Partners operates with a deep understanding that succeeding in the tech industry requires more than just funding. They actively help founders navigate the complexities of building a business, leveraging their extensive network and expertise in fintech and other innovative technologies. With a presence in major tech hubs and a portfolio fair value of £80 million as of December 2022, Forward Partners is dedicated to nurturing the next generation of leading tech businesses​.

Forward.one is a venture capital firm based in Amsterdam, Netherlands, specializing in early-stage investments in European hardware innovations. Their focus areas include semiconductors, climate tech, and high tech, supporting startups from Seed to Series B rounds with initial investments ranging from €250,000 to €5 million, and follow-on investments up to €15 million. The firm has a strong portfolio of innovative companies, such as Sensorfact, an energy efficiency platform, and ROCSYS, which develops automated charging solutions for electric vehicles. Another notable investment is Qualinx, a pioneer in semiconductor technology. Forward.one’s investment strategy is characterized by a commitment to fostering deeptech ventures that address complex problems through technological advancements. Forward.one’s approach goes beyond financial support, offering strategic guidance and leveraging their extensive network to help startups scale effectively. Their team of experienced professionals is dedicated to working closely with entrepreneurs to achieve ambitious goals, exemplifying a hands-on, supportive investment philosophy. With their second fund of €145 million, Forward.one continues to drive innovation in the hardware sector, aiming to make a significant impact on the European tech ecosystem.

Foundamental is a Berlin-based venture capital firm focused on early-stage investments in construction and industrial technology. With a mission to transform how the physical world is built and managed, Foundamental targets startups that operate in industries like construction, supply chain, logistics, and 3D design. The firm backs category-defining companies tackling the labor shortages, inefficiencies, and declining productivity prevalent in these sectors. Their notable portfolio includes Infra.Market, a major player in construction materials, Speckle, a 3D design infrastructure startup, and Snaptrude, which innovates in architectural design. Foundamental’s investment thesis centers on capturing massive, irreversible shifts in construction technology, driven by the growing global demand for infrastructure and a shrinking workforce. They look for startups at the seed and early growth stages, deploying capital from their $120 million fund. The firm’s geographic focus spans North America, Europe, and Asia-Pacific, with a strong emphasis on markets undergoing rapid urbanization and industrial change. Their strategy involves not just injecting capital but also deeply embedding in the companies they back, providing guidance on everything from technology to market dynamics. The firm’s leadership, such as co-founder Patric Hellermann, emphasizes a “craft” mentality, tailoring their approach to each startup’s unique needs rather than following rigid frameworks. Foundamental’s investments aim to build enduring companies that lead the construction and industrial tech industries, capitalizing on technology to solve the sector’s growing challenges. Founders appreciate their direct, transparent approach, making them a key player in the real-world tech transformation.

Founders Factory, established in 2015 and headquartered in London, is a prominent venture studio and startup accelerator. The firm is dedicated to building and investing in early-stage companies across various sectors, including fintech, health, climate, and deep technology. Founders Factory partners with exceptional entrepreneurs and leading companies to provide capital, bespoke support, and access to a vast network. Notable investments by Founders Factory include Shop Circle, which raised $120 million in Series A funding for its e-commerce software tools, and Scan.com, which secured $12 million in a Series A round to develop its booking infrastructure for diagnostic scans. Other significant investments include Dronamics, a company focused on ultra-efficient, long-distance cargo drones, and Iris AI, an AI engine for scientific text understanding. Founders Factory has achieved several successful exits, such as Feedr, acquired by Compass Group in 2020, and Honest Health, acquired by Hims & Hers in 2021. Their portfolio also includes innovative companies like Fundamental VR, which uses virtual reality for surgical training, and Byway, a platform for sustainable, flight-free travel.

Founders Future, established in 2018 and headquartered in Paris, France, is a venture capital firm dedicated to supporting visionary entrepreneurs across a variety of sectors. The firm primarily focuses on early-stage investments, including seed and Series A rounds. Founders Future has a robust portfolio with 148 investments and 21 successful exits to date​. Some of the notable investments include Omi, a multimedia and design software company, Veeton, and 900.care, which specializes in personal products. The firm is led by Marc Menasé, who is the founding partner, and supported by a dedicated team including Matthieu Benkerant, the Chief Operating Officer, and Sophie Duval, the Partner & General Counsel. Founders Future emphasizes a mission-driven approach, supporting startups that challenge the status quo and have the potential for multi-generational impact. They invest across various industries, from software and fintech to personal products and environmental services​. The firm's strategy includes continued financing throughout the venture lifecycle, ensuring startups receive the support they need as they grow and evolve. This approach, combined with their extensive network and expertise, makes Founders Future a valuable partner for early-stage companies looking to make a significant impact​.

Future Health Partners, headquartered in New York, is a leading venture capital firm dedicated to advancing innovations in healthcare technology. They focus on a diverse range of sectors, including HealthTech, biotech, MedTech, and healthcare IT, aiming to support companies that streamline healthcare delivery and improve patient outcomes. The firm's notable investments include leading health data analytics platforms and cybersecurity solutions tailored for healthcare, reflecting their emphasis on both operational efficiency and regulatory compliance. Recent investments highlight their commitment to digital health platforms and telehealth solutions, fostering advancements in remote patient monitoring and virtual care delivery. Future Health Partners typically invests in early to growth-stage companies, with investment rounds often ranging from Series A to Series C. They prefer to lead rounds, bringing not just capital but strategic guidance and operational expertise to their portfolio companies. Their geographic focus spans North America, Europe, and increasingly, APAC regions. The team at Future Health Partners comprises seasoned professionals with deep expertise in healthcare and technology sectors. They are proactive in seeking out startups that demonstrate strong leadership and innovative approaches to healthcare challenges. For startups looking to engage with Future Health Partners, it is essential to showcase a strong technological foundation and a clear path to improving healthcare delivery and patient experience. The firm values a well-defined business model and scalability potential, making it crucial for potential investments to align with these strategic priorities.

FOV Ventures is a European early-stage venture capital firm founded in 2021, with offices in Helsinki, London, and Paris, focused on founders building at the intersection of spatial computing, AI, 3D, and robotics. The firm is led by two Founding Partners: Dave Haynes, based in the UK, who previously led HTC's $100 million Vive X fund in EMEA and was part of the Seedcamp Fund III team and a founding team member at SoundCloud; and Petri Rajahalme, based in Finland, who was formerly Managing Director of Nordic XR Startups with eight XR investments including the successful AR-cloud exit of Immersal, and helped build the Finnish XR ecosystem through a 30 million euro Business Finland program. FOV invests at pre-seed and seed stages, writing initial checks of 100,000 to 1 million euros and leading pre-seed rounds. The firm has made 37 investments across consumer, enterprise, and industrial applications as well as infrastructure and platform-layer companies. Named portfolio companies include Move.ai, a markerless motion capture platform backed alongside Animoca and Play Ventures; Geeiq, a gaming and virtual world data intelligence company backed alongside YFM Capital and Ascension; Flow Computing, which raised a 4 million euro pre-seed for its SuperCPU technology; Distance, named Most Promising Finnish Startup in 2025; and ai|coustics, an audio AI company. Doublepoint, another FOV portfolio company, was acquired by Oura in April 2026. FOV's EDGE network includes senior leaders from Meta, Epic Games, Google, and Snap, alongside founders Matt Miesnieks of 6D.ai and Jussi Makinen of Varjo. This network provides portfolio companies with access to the most experienced operators in spatial computing — a category FOV believes will define the next major computing platform cycle.

Fraunhofer Venture is the technology transfer and venture capital arm of Fraunhofer-Gesellschaft, Europe's largest applied research organization with more than 75 institutes. Founded in 2001 and headquartered in Munich with offices in Bonn and Freiburg, the firm converts scientific research from Fraunhofer's network into investable early-stage companies. Its primary investment vehicle is the Fraunhofer Technology Transfer Fund (FTTF), with a fund volume of 60 million euros backed by the European Investment Fund and Fraunhofer-Gesellschaft under the EU's Horizon 2020 program and the European Fund for Strategic Investments. The successor fund TT49, with planned capitalization of 90 million euros and a first closing above 70 million euros announced in January 2026, will be open to any science-based German startup. FTTF invests primarily at pre-seed, with initial checks of 250,000 to 1 million euros and follow-on capacity up to 5 million euros. The firm has invested in 188 companies and supported more than 200 spinoffs across life science, medical science, energy, environment, IT, manufacturing, microelectronics, transport, logistics, materials, and photonics. In 2024 alone, 68 new spin-off projects received support. Notable portfolio exits include X-FAB Semiconductor Foundries, which listed on Euronext in April 2017 at a $1.12 billion market cap; Exocad, which was acquired; and Clean Lasersysteme, acquired by IPG Photonics in October 2024. The portfolio counts three IPOs and 20 acquisitions. The firm leads rounds. Recent investments include PerioTrap, a $3.54 million seed-stage dental biotech company backed in February 2025. Fraunhofer Venture cooperates with the AHEAD deep tech accelerator and the CoLab incubator, creating an integrated pipeline from lab to company to venture-backed scale-up. The team includes investment managers Matthias Keckl, Johann C. Siemes, and Joerg Wamser, each bringing specialized expertise in commercializing hard science from Germany's most productive applied research network.

Frazier Healthcare Partners is a leading private equity and venture capital firm that focuses exclusively on the healthcare sector. Established in 1991, the firm has raised over $7.1 billion in total capital and invested in more than 200 companies. Frazier Healthcare operates through two primary divisions: Growth Buyout and Life Sciences. The Growth Buyout division invests in profitable U.S. middle-market healthcare businesses, providing capital for growth and transformation. The Life Sciences division focuses on private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals. Recent notable exits include ARMO BioSciences (acquired by Eli Lilly) and Translate Bio (acquired by Sanofi)​. Frazier Healthcare Partners is headquartered in Menlo Park, California, with additional offices in Seattle, Washington. The firm's team comprises seasoned professionals with deep industry expertise, including Managing Partners Albert Cha, Patrick Heron, and James Topper.

Freigeist Capital, founded in 2009 by Frank Thelen, Marc Sieberger, Marcel Vogler, and Alex Koch, is a Bonn-based venture capital firm specializing in seed investments in deep tech startups across Europe. They focus on sectors like aerospace, AI, automation, biotechnology, clean energy, and robotics. Notable investments by Freigeist Capital include Lilium, an all-electric regional air mobility service; EnduroSat, a provider of nano-satellites for data services; and Kraftblock, which develops scalable thermal energy storage solutions. Other significant investments include Xentral, an ERP software for e-commerce businesses, and RobCo, which creates modular industrial robots. Freigeist Capital is known for its hands-on approach, offering comprehensive support beyond capital, including help with product development, business strategy, and scaling operations. They invest their own money, allowing for quick decision-making and long-term commitment without pressure for quick exits.

Fresenius Medical Care is a global leader in providing products and services for individuals with renal diseases, managing the care of approximately 4.1 million patients worldwide. The company operates over 4,000 dialysis clinics and offers an extensive range of products for in-center and home dialysis, including dialysis machines and related disposables. Strategically, Fresenius is focusing on three core areas: the renal care continuum, critical care solutions, and complementary assets. This approach involves new renal care models, such as personalized dialysis and home care, value-based care, and advancing treatments for chronic kidney disease (CKD) and transplantation. The company is committed to enhancing healthcare for chronically and critically ill patients, aiming to offer high-quality, sustainable solutions at reliable costs. Fresenius Medical Care is also in the midst of a significant portfolio optimization program. In 2023, the company executed several strategic divestments to focus on businesses with the best strategic fit and greatest scale, while also improving its leverage ratio by allocating proceeds from these divestments​.

Friále is a seed-stage venture capital firm that invests in startups worldwide, with a focus on follow-on investments as companies grow. Founded by Bryan Frist, Friále is known for its founder-centric approach, acting as the type of investors they would want on their own cap tables. Their investment strategy is to back promising entrepreneurs early, typically offering investment amounts ranging from $100K to $600K, with a sweet spot around $350K. Friále's portfolio spans various sectors, including SaaS, marketplaces, and enterprise solutions. They co-invest with prominent firms like Andreessen Horowitz, Y Combinator, and Kleiner Perkins, ensuring a robust support network for their portfolio companies. Geographically, Friále has a strong presence in Nashville and the San Francisco Bay Area, targeting innovative startups in these vibrant ecosystems. They have a track record of supporting companies that are solving significant problems with scalable solutions, particularly those that demonstrate strong product-market fit early on.

Frog Capital is a growth capital firm specializing in European software scale-ups that are purpose-driven. They invest in high-growth software businesses that have achieved at least €3 million in annual recurring revenue (ARR) and are making a positive social impact. Typical transactions range from €5 million to €30 million. Frog Capital focuses on providing not just capital but also strategic support through their Scale-Up Methodology, which includes practical toolkits, podcasts, and insights aimed at helping businesses grow while retaining their core values and purpose​​. Their portfolio includes notable investments in companies like McMakler, Modulr, and Evotix. Frog Capital has a strong track record of successful exits, including Sellics and Azimo​​. The firm's geographic focus is on Europe, with a particular interest in software sectors such as fintech, proptech, and edtech. Frog Capital's team comprises experienced professionals like Senior Partners Steven Dunne and Jens Düing, who bring a wealth of knowledge from various tech sectors. They support their portfolio companies with a hands-on approach, offering expertise in scaling operations and maintaining sustainable growth​​. For entrepreneurs seeking investment, Frog Capital looks for companies that are scaling rapidly, have a strong product-market fit, and are committed to their social impact. Their approach ensures that businesses not only grow commercially but also continue to align with their original purpose​.

Frontline Ventures, founded in 2012, is a venture capital firm with a focus on early-stage and growth-stage investments in B2B software companies. Based in Dublin, Ireland, and with additional offices in London and San Francisco, Frontline Ventures aims to support globally ambitious startups on both sides of the Atlantic. Frontline's notable investments include Workvivo, which was later acquired by Zoom, and Pointy, which was acquired by Google. Other significant investments are in companies like Signal AI, a platform providing real-time insights for media monitoring, and MosaicML, which offers managed infrastructure and tools for training machine learning models. The firm manages two primary funds: Frontline Seed and Frontline Growth. Frontline Seed targets early-stage European startups, helping them navigate their initial growth phases and set the foundation for successful Series A rounds and beyond. Frontline Growth, on the other hand, focuses on scaling established companies and facilitating their entry into the US market, leveraging Frontline's extensive network and expertise. Frontline Ventures places a strong emphasis on supporting companies with potential for significant impact and growth, often aiming to guide them towards eventual public listings. This strategic approach helps ensure that the startups they back are not only innovative but also positioned for long-term success. Frontline Ventures' commitment to fostering innovation and supporting ambitious founders has established it as a key player in the venture capital landscape, particularly within the European and transatlantic startup ecosystems.

Frumtak Ventures is Iceland's leading venture capital firm, founded in 2008 and headquartered in Reykjavik. The firm takes a high-conviction, high-involvement approach from seed stage through IPO, championing founders who have demonstrated early traction and have the potential for international growth. Frumtak has raised four funds, including Fund III at $57 million and Fund IV at $87 million — oversubscribed and closed in July 2024, backed primarily by Icelandic pension funds. Initial ticket sizes range from 1 million to 3 million euros, and the firm leads rounds. The eight-person team includes Managing Partner and co-founder Svana Gunnarsdottir, a serial entrepreneur, alongside General Partners Asthildur Otharsdottir and Andri Heidar Kristinsson, with a consensus-driven investment process. Frumtak invests at the intersection of software, AI, and deep tech in industries aligned with Iceland's historical strengths: ocean technology, logistics, healthcare, travel, energy, climate, and gender equality. The portfolio of 30 companies has produced five exits including Kaptio, a travel CRM exited in November 2024; Valka, Main Manager, and Trackwell. Named portfolio companies include Sidekick Health, a gamified digital care platform partnered with Anthem US; Controlant, a cold chain logistics visibility platform; and Meniga, a digital banking personalization company. Recent deals include Optise, an AI website insights company; MyDello, a logistics platform that raised 3.1 million euros; and Euler, an AI 3D printing startup that raised 2 million euros at pre-seed. Frumtak's approach emphasizes a long partnership horizon rather than a transactional investment relationship. The consensus-driven decision process ensures alignment among partners before any commitment, and the firm's concentrated portfolio model allows it to engage meaningfully with each company from the first check through to exit or public listing.

FTV Capital (formerly Financial Technology Ventures) is a San Francisco-based growth equity investment firm founded in 1998 by Jim Hale and Robert Huret. The firm focuses on high-growth companies in three sectors: enterprise technology and services, financial services, and payments and transaction processing. FTV has raised over $10.2 billion across multiple funds, invested over $6.7 billion in 149 portfolio companies, and realized over $7.4 billion. In January 2025, FTV completed a record $4.05 billion fundraise: FTV VIII closed oversubscribed at $3.4 billion and Ascend I at $651 million. In 2024 alone, the firm deployed a record $1.6 billion and generated over $1.0 billion in realizations. The firm maintains offices in San Francisco, New York, Connecticut, and London. FTV leads its investments and writes checks of $10 million to over $100 million, focusing on Series B and later growth-stage rounds. Notable portfolio companies include Payoneer, eToro, GreenSky, Agiloft, Kore.ai, and BillingPlatform. Recent exits include Agiloft, Docupace, Egress, and Tango Card. Managing Partner Brad Bernstein leads the investment team alongside Co-COO Karen Gilbert, Partner Alex Malvone (co-head of FTV Ascend), and Partner Brent Fierro. FTV has created an estimated $45 billion in enterprise value across its portfolio. FTV's differentiation comes from two proprietary assets: its Global Partner Network of more than 600 executives from leading enterprises, and FTV Propel, an in-house operational support team. These resources accelerate commercial traction, talent acquisition, and strategic partnerships for portfolio companies, moving beyond capital provision to genuine operational leverage.

Fulgur Ventures is a venture capital firm founded in 2019 in Wilmington, Delaware, focused exclusively on Bitcoin and Lightning Network startups. The firm is led by partners Vitaly Bezrodnykh, who brings a background in IT and computer security from Hewlett Packard, Vertical Networks, and Kaspersky Lab with expertise in international business development and M&A; and Oleg Mikhalsky, an angel investor since 2008 and hands-on entrepreneur with a successful exit and an MBA in strategic management. Fulgur operates with a team of four and a conviction that Bitcoin represents a next-generation, politically neutral monetary system and the foundation for decentralized finance. Fulgur writes initial checks of $50,000 to $200,000 for pre-seed startups, provides grants for ecosystem contributions, and invests at later stages in existing relationships. As of March 2026 the portfolio includes 93 investments across financial infrastructure, payments, exchanges, wallets, and Bitcoin ecosystem tools. Notable portfolio companies include Blockstream and Sygnum, both of which became unicorns; Fold, which completed a NASDAQ IPO in February 2025; Relai, a Swiss Bitcoin savings app; ZEBEDEE, a Bitcoin gaming payments platform; Amboss, a Lightning Network data intelligence company; OpenNode, a Bitcoin payments processor; Breez, a Lightning wallet; and Foundation Devices, a hardware wallet manufacturer. The portfolio has produced four acquisitions including Future Holdings, acquired by H100 Group in January 2026. In 2025, the firm made nine new investments. Fulgur also helps portfolio companies navigate cryptocurrency legal and regulatory environments, a substantive value-add given the rapidly shifting global regulatory landscape for Bitcoin-native businesses. The firm's deep specialization in the Bitcoin and Lightning ecosystem, sustained across more than 90 investments, makes it one of the most experienced and active venture investors dedicated exclusively to this category.

Fund+ is a Belgian venture capital firm that focuses on long-term equity investments in innovative life sciences companies. Established in 2015, the firm aims to create both financial returns and a positive societal impact, primarily investing in therapeutics, diagnostics, and medical devices. Fund+ seeks to address unmet medical needs, with a patient-centric approach. The firm typically invests between €5 million and €15 million per project and plays an active role in its portfolio companies, often taking a seat on the board to provide strategic guidance. With over €200 million in assets under management, Fund+ has built a strong track record, investing in 13 high-potential companies, with two notable exits. The firm's portfolio includes companies such as Indigo Diabetes, which is developing a revolutionary invisible glucose monitoring device, and ExeVir Bio, which focuses on antiviral nanobody treatments for global viral threats. Fund+ also supports companies like Novadip Biosciences, which is developing advanced tissue regeneration therapies, and Confo Therapeutics, known for its groundbreaking GPCR-targeted drug discovery platform. Fund+ operates with a long-term vision, aiming to bolster the life sciences ecosystem in Belgium while fostering innovations that improve patient outcomes globally. Its diverse portfolio reflects a commitment to supporting groundbreaking scientific advancements that have the potential to transform healthcare.

Fuse Venture Partners is a London-based venture capital and corporate advisory firm founded in 2005, formerly known as Global Venture Partners. The five-person team advises, supports, and invests in high-growth European technology companies, combining decades of corporate finance experience across mergers and acquisitions, capital raising, and exits with hands-on operational expertise. The firm invests at venture-growth stages — primarily Series B and Series C — with a sweet spot of $5 million and a range of $1 million to $30 million, across two funds. Fuse has made 15 investments with three unicorn outcomes: Kurly, a Korean premium e-commerce platform; Jobandtalent, a European workforce management platform; and Forto, a digital freight and logistics company. Other portfolio companies include Carbon Robotics, which raised a Series D in October 2024; Gallabox, a conversational commerce platform; Casavo, a real estate transaction platform; and Envive, a business software company backed in September 2025. A recent exit was Symbiosys in June 2025. The firm's portfolio spans consumer, enterprise applications, food technology, and logistics. Fuse's corporate advisory heritage shapes how it engages with portfolio companies: beyond capital, the firm provides transaction structuring, strategic guidance through key inflection points, and direct introductions to co-investors and acquirers drawn from its network with Europe's largest tech VC firms and other institutional investors. This combination of financial engineering expertise and venture growth experience is particularly valuable for European scale-ups navigating large fundraising rounds, strategic partnerships, and eventual exit processes.

First Ever Ventures (FEV), also known as UVF, is a venture capital firm focused on impactful investing. Established with the mission to do good while doing well, FEV has a diversified portfolio that spans various sectors. They prioritize investments in innovative companies that aim to generate significant social and environmental impact while achieving substantial financial returns. Their notable investments include companies like Recycleye, which provides AI-powered recycling technology; Edovo, an education technology company focused on providing quality education to incarcerated individuals; and GoReact, a video assessment platform for skills-based learning. These investments highlight FEV's commitment to supporting ventures that offer transformative solutions in their respective fields. First Ever Ventures is structured around a unique investment model that leverages the involvement of motivated students and experienced professionals to deploy catalytic capital, primarily in the Intermountain West and beyond. This model not only supports high-impact startups but also contributes to the development of future leaders in venture capital and social entrepreneurship.

Future Food Fund is a Dutch venture capital firm dedicated to driving sustainability within the food and agriculture sector. Established in 2017, the fund focuses on early-stage investments, particularly in companies that are innovating across the food value chain. Their areas of interest include regenerative agriculture, alternative proteins, smart farming, and circular food systems. Future Food Fund seeks to support startups that can address critical environmental challenges and contribute to building a sustainable food ecosystem. Recently, Future Food Fund II, their second impact-driven fund, successfully raised €40 million. Backed by notable partners such as the European Investment Fund (EIF) and regional organizations like Wageningen University & Research, Oost NL, and NOM, the fund aims to accelerate early-stage agritech and food startups across Western Europe. The firm positions itself as more than just a source of capital; it is seen as a catalyst for change, fostering innovation that can mitigate the environmental footprint of current food systems. Their portfolio includes startups such as NoPalm Ingredients and Pectcof, focusing on sustainable ingredient production, and EV Biotech, which works on precision fermentation. With a strong network of partners, Future Food Fund emphasizes collaborative growth, providing both capital and strategic support to ensure startups can scale effectively and deliver impactful solutions​.

Future Industry Ventures is a specialized venture capital fund dedicated to driving the evolution of industrial systems through strategic investments in Industry 4.0 technologies. The fund is headquartered in Luxembourg and Berlin, with a Pan-European investment focus. It targets companies at the early and growth stages that are poised to revolutionize manufacturing, automation, sustainability, and cybersecurity. The fund's investment philosophy is rooted in the belief that decentralization, enhanced connectivity, sustainability, and security are the key drivers of future industrial innovation. By focusing on these areas, Future Industry Ventures aims to support the transformation of traditional industries into more efficient, connected, and environmentally responsible systems. The fund typically makes initial investments ranging from €2 million to €10 million, with the potential for follow-on funding as companies progress. Co-managed by SBI Holdings, Redstone Digital, and Future Industry Ventures, the fund leverages a unique combination of global tech investment expertise and deep industry connections. This partnership allows them to provide not only capital but also strategic guidance and access to a broad network of industry leaders and innovators. Their portfolio includes companies that are at the forefront of implementing cutting-edge technologies in industrial automation, advanced manufacturing, and sustainable industrial processes. Future Industry Ventures is committed to shaping the future of industry by supporting companies that are developing the next generation of industrial technologies. With a strong focus on Europe, the fund is well-positioned to lead the charge in the global shift toward more intelligent, connected, and sustainable industrial systems.

Future Positive Capital is a Paris-based venture capital firm that focuses on investing in advanced technology companies that address global challenges at a planetary scale. The fund emphasizes sustainable innovation and supports entrepreneurs who are driving systemic changes in sectors like health tech, green energy, robotics, and more. Notable investments include Ouihelp, Brilliant Planet, Circulor, and Aerones, companies that lead in areas such as elderly care, renewable energy, and biodiversity restoration. Founded in 2016, Future Positive Capital typically invests in Series A to C stages, with check sizes ranging from €500,000 to €3 million. Their investment thesis revolves around fostering long-term societal, technological, and environmental impact. The firm places a strong emphasis on backing entrepreneurs whose innovations have the potential for large-scale societal progress, and it leads or co-leads many of the funding rounds it participates in. Sofia Hmich, the co-founder and managing partner, leads the firm alongside a dedicated team. With a clear mission to shape preferable futures, Future Positive Capital builds close partnerships with startups, providing both capital and strategic support to help them scale

Future Shape LLC is an investment and advisory firm founded by Tony Fadell, known for his work at Apple and Nest Labs. Based in Paris, France, the firm focuses on deep technology, investing in engineers and scientists developing groundbreaking technologies. Founded in 2014, Future Shape primarily engages in seed investments but is also involved in later-stage funding under specific conditions. The firm's investment portfolio spans multiple sectors, including agriculture, energy, transportation, medical diagnostics, financial services, consumer products, and robotics. Notable investments include companies like Phononic, Modern Meadow, Weave, Simbe Robotics, and Vium. Future Shape is known for its hands-on approach, providing not just capital but also strategic guidance in areas such as product-to-market fit, branding, user experience, and go-to-market strategies. Future Shape typically invests amounts ranging from $100K to $10M, with a focus on early-stage companies in the US and Europe, though it occasionally invests in Asia and the Middle East. The firm's approach integrates extensive collaboration and advisory services, helping startups navigate the complexities of commercialization and scale their innovations effectively. Led by Tony Fadell, Future Shape leverages his extensive experience and network to support the growth and success of its portfolio companies, making it a key player in the venture capital landscape for deep tech startups.

G+D Ventures is the corporate venture capital arm of Giesecke+Devrient, a global security technology company. Active since 2018 and based in Munich, Germany, the firm was founded by experienced venture capitalists and has established a 50 million euro co-investment vehicle with the European Investment Bank and G+D, dedicated to early-stage European TrustTech startups across the EU-27. The team includes partners Assaf Shamia, formerly of Carmel Ventures and Viola Group and previously at Siemens VC, and Dr. Michael Hochholzer, who has been active in venture capital since 2001 and was formerly Managing Partner at Siemens VC and investment manager at Infineon Ventures and Baytech VC. TrustTech, the firm's proprietary investment category, extends the traditional definition of cybersecurity to include technologies across four layers: digital infrastructure including cybersecurity, secure data collaboration, and privacy-preserving techniques; identity including KYC, authentication, and identification; regulatory technology including anti-money laundering and anti-fraud; and ethical AI including deepfake detection and fake news detection. The firm invests at seed and Series A, leading rounds, and has made 17 investments. Named portfolio companies include Blockbrain, an AI knowledge management company that raised a 17.5 million euro Series A; Roseman Labs, a secure data collaboration company backed in September 2025; FNA, a financial network analytics company focused on CBDC simulation; and Tremau. Notable exits include IDnow, an identity verification company acquired by Corsair Capital in one of the largest German fintech exits, and Brighter AI, a data anonymization company acquired by Milestone Systems in April 2025. G+D Ventures also publishes the European TrustTech Report, an annual assessment of the sector that reinforces the firm's position as an authoritative voice in the emerging digital trust ecosystem. This thought leadership, combined with G+D's operational expertise in secure communications and identity technology, gives portfolio companies access to both capital and deep industry credibility.

G+J Digital Ventures is a corporate venture fund established at the end of 2015 by German media groups Gruner + Jahr and the Bertelsmann Group, based in Berlin. The fund encompassed a volume of EUR 50 million composed of a combination of cash and media investment, and was led by Managing Directors Nicolas J. Kirschner and Beate Koch. The firm focused on scalable early-stage digital companies in e-commerce, healthtech, and software that had already demonstrated an initial proof of market, making six investments at the seed and Series A stages. G+J Digital Ventures invested between $1 million and $3 million per company, providing portfolio companies not only with capital but also access to Gruner + Jahr's considerable digital and print media reach and the global network of the Bertelsmann Group. Portfolio companies included InstaMotion (automotive e-commerce), Bring! Labs (a shopping app), Pamono (a design marketplace), Makerist (DIY and crafting platform), and Temedica (healthtech). The fund achieved three portfolio exits, including InstaMotion, which exited in July 2024. The fund operated across Europe with investments individually adapted to each venture's needs, reflecting the media group's preference for companies at the intersection of digital consumer behavior and scalable technology. Following the merger of Gruner + Jahr into RTL Deutschland in 2021, Beate Koch moved to RTL Ventures. The fund made its last recorded investment in March 2021 and effectively ceased new investment activity as a result of the broader Gruner + Jahr and RTL Deutschland reorganization.

GAN Ventures, based in Denver, is a venture capital firm that focuses on investing in global, early-stage companies with high growth potential. As part of the Global Accelerator Network (GAN), the fund is driven by a mission to support founders with integrity, self-awareness, and the ability to scale. GAN Ventures targets a wide range of industries including SaaS, fintech, healthcare, and consumer products, backing startups like Buderflys, CleanRobotics, and Pomp. The firm offers catalytic capital to founders across the world, particularly those who are graduates of GAN’s accelerator programs. With a typical check size of around $100k, GAN Ventures focuses on the pre-seed and seed stages, and they prioritize companies that align with their values of sustainability, innovation, and community impact. Unlike many traditional VCs, GAN Ventures builds close, long-term relationships with founders, helping them through mentorship, resources, and connections within their vast global network. The firm’s co-founders, Patrick Riley and Reilly Flynn, bring deep expertise from their backgrounds at Techstars and various leadership roles in venture-backed companies. GAN Ventures doesn’t just provide financial backing but also helps portfolio companies navigate critical growth phases, ensuring that they are well-equipped to succeed in competitive markets. By leveraging GAN’s global reach, the firm has established a strong presence in regions like North America, Europe, and Africa, supporting companies that create meaningful change in their industries.

Gandyr Group, based in Herzliya, Israel, is a private family investment firm that focuses on long-term investments in stable, high-growth industries both locally and internationally. Founded with a commitment to impactful and sustainable investing, Gandyr operates across sectors such as industrials, technology, renewable energy, and real estate. The firm is known for its strong focus on supporting Israeli companies with a global reach, fostering their growth through strategic partnerships and capital. Gandyr’s portfolio reflects its diverse interests. Notable investments include Mobileye, a leader in autonomous driving technology, which achieved a historic IPO and was later acquired by Intel. The firm also backs Yotpo, a unicorn in the e-commerce marketing space, and Sofwave Medical, an innovative aesthetic technology company now listed on the Tel Aviv Stock Exchange. Other investments span AI-driven healthcare solutions like NYM Health and emotional support platforms such as Circles. Beyond technology, Gandyr invests in sustainability-focused ventures like K.B Recycle Industries, which specializes in polyethylene recycling, and infrastructure companies like Tower Vision, a telecom tower operator in India. The firm's involvement in UpWest Labs, a seed-stage fund in Silicon Valley, demonstrates its commitment to fostering Israeli innovation on a global scale. Gandyr’s approach blends financial performance with positive social and environmental impacts, making it a key player in Israel’s venture ecosystem.

Gastro Ventures is a food-technology innovation hub founded in 2018, based in Sant Cugat del Valles, Catalonia, Spain, near Barcelona. The firm operates at the intersection of food science, culinary arts, and technology, and was built around a commitment to innovation, disruption, and sustainability in the food industry. Gastro Ventures runs two investment vehicles: Koete Food Venture Fund I, which invests in international foodtech early-stage opportunities, and Koete Food Venture Builder I, which backs spin-off companies it creates internally. The firm maintains its own food technology R&D laboratories and develops proprietary companies alongside its external investment activity. Internally developed ventures include Alacarte (an alcohol and spirits brand), 1933 Signature Cocktails, Carrot (a culinary partner for high-end hotels), and Gastronomy Solutions. Gastro Ventures is the co-organizer and principal sponsor of the Science and Cooking Public Lectures at Harvard University in Boston and the Science and Cooking World Congress, positioning the firm at the leading edge of food science research and applied culinary innovation globally. Gastro Ventures functions more as a food-technology innovation studio and venture builder than as a traditional venture capital fund. The firm invests at the pre-seed and seed stages, focused primarily on European food technology opportunities. Limited public information is available on external portfolio investments, specific fund size, or individual team members beyond the firm's own described ventures.

GBV Capital (Genesis Block Ventures) is a web3-exclusive investment firm founded in 2020, headquartered in Hong Kong. The firm manages over $200 million in assets under management and invests exclusively with its own capital -- there are no limited partners. GBV focuses on blockchain technology, digital currency, and cryptocurrency investments, concentrating on early-stage teams with the highest potential across the entire Web3 spectrum. The firm invests $100,000 to $1.5 million at the pre-seed, seed, and Series A stages. GBV has built a portfolio of 115 investments spanning decentralized finance (DeFi), layer-one and layer-two protocols, infrastructure, data, artificial intelligence, real-world assets, launchpads, media, custodians, NFTs, metaverse, gaming, and social applications. Of these, the firm counts over 50 successful projects, with 35 DeFi projects, 25 NFT projects, 15 Web3 projects, and 8 infrastructure projects as the largest categories. The firm has recorded five exits, with the most recent being Moongate in June 2025. Recent investments include DePin (Seed, June 2025) and participation in Tevaera's $5 million blockchain gaming round. GBV's investment philosophy is rooted in the blockchain ethos of iteration, community building, and resilience, and the firm prioritizes backing gritty teams with strong product conviction and community traction. Operating without LP capital gives GBV flexibility in deployment timing and structure that external-fund managers cannot replicate, allowing the firm to take long-duration positions across the volatile Web3 investment cycle.

GE Ventures, the venture capital arm of General Electric, focuses on transformative investments in healthcare, energy, and advanced manufacturing. Notable portfolio companies include Bright Health, Xage Security, and Desktop Metal. GE Ventures invests from early to late stages, often leading rounds, with a typical annual investment up to $150 million. The firm is based in Menlo Park, CA, and prioritizes North American opportunities. Their strategy emphasizes alignment with GE's industrial expertise, aiming for investments that can leverage GE’s vast resources. The team, led by CEO Sue Siegel, consists of experts experienced in scaling technological innovations. Startups should showcase strong tech innovation and potential integration with GE’s platforms. Approaching GE Ventures is best done through their extensive network for warm introductions. Recent activity highlights their strategic impact, with investments and successful exits in companies like SolarEdge Technologies and Arcadia Solutions, demonstrating their commitment to fostering growth and innovation in their targeted sectors​.

Gecad Ventures is a Bucharest-based venture capital firm founded in 1992 by Radu Georgescu. The firm specializes in early-stage investments, focusing on technology companies in Central and Eastern Europe (CEE). Gecad emphasizes sectors such as cybersecurity, fintech, AI/ML, IoT, and agritech, aiming to support startups with strong international scaling potential. Typical investments range from €100K to €1.5M, targeting both seed and Series A rounds. Gecad has achieved notable exits, including Vector Watch, sold to Fitbit, and Kare Knowledgeware, acquired by Dialpad. They also led investments in TypingDNA, a cybersecurity startup, and Smart Bill, a Romanian billing software provider. Gecad Ventures is well-regarded for helping CEE startups expand into international markets, fostering rapid growth and global presence. Their investment strategy is built around creating strong relationships with founding teams and offering strategic advice, particularly to help companies expand into larger tech ecosystems. With deep experience in the tech sector, Gecad Ventures plays a significant role in the European venture capital landscape.

General Atlantic, founded in 1980 and based in New York, is a global growth equity firm with a significant focus on sectors including technology, consumer, financial services, healthcare, life sciences, and climate. The firm manages approximately $84 billion in assets and operates across multiple global regions including the United States, Europe, China, India, Southeast Asia, and Latin America. General Atlantic's investment strategy emphasizes long-term partnerships with entrepreneurs and businesses, leveraging their extensive capital resources and strategic expertise to help companies scale globally. The firm has a history of investing in transformative businesses and helping them achieve market leadership. Notable portfolio companies include Airbnb, Uber, and ByteDance, among others​. In recent years, General Atlantic has also focused on climate-related investments through its BeyondNetZero initiative, which targets growth equity investments in companies addressing climate change. This initiative is part of their broader commitment to responsible investing and sustainability​.

Generate Capital is a San Francisco-based investment firm specializing in sustainable infrastructure and energy transition projects. Established in 2014 by Scott Jacobs and other co-founders, Generate Capital focuses on long-term investments that provide both financial returns and significant environmental impact. The firm operates as a permanent capital investment platform, meaning it deploys patient capital through a mix of debt and equity financing, enabling sustainable projects to scale rapidly without the typical pressures of short-term returns. Generate's strategy is centered on funding clean energy, energy efficiency, water, waste, and transportation projects that are critical to building the sustainable infrastructure of the future. Notable investments include ventures like Pine Gate Renewables, a solar and storage developer, and GrowUp Farms, a leading vertical farming company in the UK. By investing across the lifecycle of sustainable projects—from inception to growth—Generate Capital provides both capital and operational expertise, partnering closely with the companies it backs to ensure long-term success. With a recent capital raise of $1.5 billion, Generate Capital has continued to expand its portfolio, which includes more than 50 companies globally. Its focus on building infrastructure that supports the energy transition aligns with growing global efforts to decarbonize the economy and promote sustainability. The firm operates internationally, with offices in San Francisco, New York, and Washington D.C., and it continues to lead the charge in sustainable infrastructure investments.

Generation Investment Management, co-founded by Al Gore and David Blood in 2004, is a global sustainability-focused investment firm headquartered in London. The firm pioneers an approach that integrates sustainability with traditional long-term investing, believing that financial returns and positive environmental and social impacts can coexist. Generation focuses on companies that exhibit strong environmental, social, and governance (ESG) practices and demonstrate leadership in transitioning toward a more sustainable economy. The firm primarily invests in public equities but also has a private equity arm targeting innovative companies in sectors like clean energy, sustainable food systems, and healthcare. Notable investments include companies like Beyond Meat and Asana, which align with their mission to drive long-term sustainable outcomes. Generation emphasizes high-conviction, concentrated portfolios and takes a global perspective, with investments spread across North America, Europe, and Asia. Generation’s strategy involves rigorous research, with a focus on identifying companies with a strong commitment to sustainability, long-term growth potential, and competitive advantage. The firm is known for its hands-on approach, often engaging with the companies they invest in to promote better ESG practices. The leadership team includes experienced professionals like CEO David Blood, along with key partners who bring deep expertise in finance and sustainability. Al Gore, as the face of the firm, continues to advocate for climate action and responsible investment practices, reinforcing Generation's reputation as a pioneer in sustainable finance. This dual focus on impact and returns has cemented its place as a leader in the evolving landscape of ESG investing..

Genesis Ventures is an angel co-investment fund founded in 2021 and based in Athens, Greece, providing pre-seed and seed capital alongside hands-on support to early-stage founders in Greece and Southeast Europe. The fund is backed by the European Investment Fund (EIF) as well as leading angel investors including previous successful founders, family offices, and industry veterans. General Partners Stergios Anastasiadis and Dimitrios Maroulis lead the firm; Maroulis built and invested in approximately 100 early-stage technology startups across North America and Asia before returning to Greece. Genesis targets EUR 40 million in total venture capital equity investment by co-investing alongside business angels, aiming to support 60 or more pre-seed and early-stage ICT companies. Check sizes range from EUR 100,000 to EUR 400,000. The fund invests across enterprise SaaS, fintech, healthcare, e-commerce, deep tech, edtech, proptech, and Web3. The portfolio of 20 companies includes Terra Robotics (EUR 1.8 million round in September 2025, robotics and AI-powered laser weeding for sustainable farming), Xatoms ($3 million, AI-powered water purification), and Billys (property technology). The firm has made five investments in 2025, averaging three per year over the prior three years. Genesis Ventures describes its ambition as making Greece a unicorn producer and a regional technology hub for the broader Southeast European region. By coupling institutional EIF backing with the domain expertise of experienced angel investors, the fund bridges the gap between angel-stage capital and formal venture funding in a market where that gap has historically been wide.

Genoa Ventures stands at the intersection of biology and technology, investing in early-stage companies that are poised to revolutionize their industries. Their portfolio includes trailblazing startups like Ionpath and BRAINBox Solutions, reflecting a keen focus on research tools, diagnostics, Agri/Food Bio, and industrial biology. Headquartered in San Francisco, Genoa has a strong geographic focus on North America. Genoa's investment strategy zeroes in on seed and Series A rounds, aiming to be an active partner rather than just a financial backer. The firm typically leads rounds with average checks ranging from $500K to $5M. Their approach emphasizes long-term relationships and strategic guidance, leveraging the team's extensive background in scientific research, technology development, and entrepreneurship. This hands-on involvement ensures that portfolio companies receive the support they need to scale effectively. The team is led by founder and managing director Jenny Rooke, Ph.D., who has a rich background in both the scientific and investment realms. Genoa's partners bring a unique blend of experience, having worked across various capacities in the life sciences and tech sectors. This diverse expertise enables Genoa to identify and nurture companies that others might overlook. For startups looking to engage with Genoa, it's best to approach them with a clear demonstration of how their technology intersects with biology to solve significant problems. The firm values early identification of technological advantages and market potential, making them a pivotal partner in driving innovation forward.

Geometry Venture Development (Geometri Melek Yatirim Fonu) is a Turkish angel investment fund founded in July 2019 by Melih Efeoglu and based in Istanbul. The fund operates under a rolling fund and syndicate model, dedicated to empowering early-stage technology startups at the problem-solution and go-to-market stages. Efeoglu specializes in cybersecurity, deep tech, and biotech, and the fund's check sizes range from $20,000 to $50,000 per company, with some deals reaching $250,000 as part of syndicated rounds. The team comprises four people and has built a portfolio of approximately 20 companies across Turkey, the United Kingdom, and the United States. Portfolio companies span education, healthtech, AI, cybersecurity, hardware and IoT, virtual reality, and sustainability. Known investments include Enhencer (AI-powered advertising), HoustonBionics (biotech), Sweephy (data platform), Sensgreen (indoor air quality IoT), Scoutli (sports analytics), Postuby (design automation), DatAnchor, Pangea VR (virtual reality), FenixPyre (cybersecurity), Sorbil (educational software, latest investment October 2023), and Barty Digital. One portfolio exit has been recorded: Nebyan Dogal, exited June 2025. Limited partner Uygar Mesudiyeli has supported the fund's formation. Geometry Venture Development's rolling fund and syndicate structure gives the firm flexibility to move quickly on compelling early opportunities and to bring in co-investors at varying check sizes depending on deal requirements. The firm has not reported new investments in 2025, and its last publicly recorded deal dates to October 2023.

Giant Ventures, founded in 2019, is a venture capital firm that invests in purpose-driven technology companies. The firm focuses on three primary themes: climate, health, and inclusive capitalism. Headquartered in London with additional offices in Los Angeles, New York, Stockholm, and Copenhagen, Giant Ventures has launched two new funds totaling $250 million. These include a $100 million seed fund targeting early-stage companies and a $150 million climate-focused growth fund aimed at addressing the Series B climate funding gap. The leadership team, including co-founders Cameron McLain and Tommy Stadlen, brings extensive experience as former founders and operators. They are supported by a distinguished advisory board featuring prominent figures such as former BP CEO Lord Browne and 23andMe co-founder Linda Avey. Their network also includes alumni from Revolut, Microsoft, Deliveroo, Babylon Health, and Y Combinator. Giant Ventures has backed notable companies like Calm, Agreena, and Field, and has already made 10 investments from its new funds. The firm aims to create significant impact by partnering with ambitious founders who use technology to address pressing global challenges, such as climate change and healthcare improvements. Giant Ventures' investors include a broad alliance of institutional investors and prominent individual backers, such as BMW, Henkel, and Sir Richard Branson.

Gilde Healthcare, headquartered in Utrecht, Netherlands, with offices in Boston and Frankfurt, is a leading European venture capital firm specializing in healthcare investments. Gilde manages €2.6 billion across its Venture&Growth and Private Equity funds. The Venture&Growth fund focuses on healthtech and therapeutics, investing in early revenue or clinical stage companies in Europe and North America, with notable investments in companies like Lava Therapeutics and CVRx. Their typical equity investments reach up to €50 million, often taking significant minority stakes. The Private Equity fund targets profitable mid-market European healthcare providers and medical product suppliers, including investments like Symeres and Acti-Med​. The firm's strategy emphasizes improving care at lower costs, supported by an expert team of industry veterans, scientists, and entrepreneurs who offer hands-on growth strategy support. Gilde prefers to lead investment rounds and is particularly active in sectors like drug delivery and digital health. For startups seeking investment, it's beneficial to approach Gilde with a strong value proposition in healthtech or therapeutics, demonstrating clear potential for cost-effective healthcare improvements. Key team members include co-founders Edwin de Graaf and Pieter Van der Meer, who bring decades of industry expertise to their leadership roles​.

Gimv, founded in 1980 and headquartered in Antwerp, Belgium, is a prominent European investment firm listed on Euronext Brussels. Gimv focuses on building and growing innovative companies through its five strategic investment platforms: Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. With around €1.56 billion in portfolio value and investments in approximately 60 companies, Gimv leverages over 40 years of experience to partner with entrepreneurial and ambitious management teams. The firm supports companies with capital requirements ranging from €5 to €75 million, primarily focusing on those headquartered in the Benelux region, France, and DACH countries. Gimv's investment strategy emphasizes sustainable growth and value creation, utilizing various growth levers such as internationalization, innovation, and digitalization. The firm’s commitment to sustainability is integrated into its operations and investment decisions, promoting ESG (Environmental, Social, and Governance) principles across its portfolio.

Founded in 2015, Geneva-based Ginko Ventures is a high-impact venture capital firm focused on advanced technology companies in Europe and Israel. With a distinct preference for sectors like connected devices, robotics, big data, cloud infrastructure, and software intelligence, Ginko invests in scalable businesses that enhance the ways people work, play, and live. The fund targets growth-stage companies with innovative, global applications, and a few of its standout investments include French audio-tech leader Devialet and IoT platform Actility, both of which benefit from Ginko’s commitment to accelerating disruptive technology’s market reach. Led by Jean-François Baril, former Nokia executive, Ginko Ventures is highly selective, prioritizing companies capable of driving market transformation. Their investment strategy is notably collaborative, often leading rounds with substantial check sizes to fuel both R&D and market expansion. Ginko's team, deeply experienced in tech and engineering, brings both capital and strategic guidance, helping portfolio companies break into international markets, especially across Asia and the U.S. Known for a hands-on approach, Ginko partners closely with founders and prefers strategic partnerships that align with their global expansion vision.